Table 2.
Standardized Mean Annual Estimates of Costs in 2010 Dollars for Elevated BMI and Pediatric Hypertension Groups, without Controlling for Comorbidity (N=208,800 child-years)
| Inpatient Mean (SE) |
Outpatient Mean (SE) |
Pharmacy Mean (SE) |
Total Mean (SE) |
|
|---|---|---|---|---|
| BMI percentile | ||||
| BMI < 85 | 75 (3) | 547 (4) | 201 (5) | 822 (8) |
| 85<= BMI<95a | 81 (65) | 599 (8) | 251 (26) | 954 (45) |
| BMI >= 95b | 88 (5) | 609 (8) | 249 (8) | 937 (13) |
| Pediatric Hypertension | ||||
| Normal BP | 58 (3) | 477 (4) | 197 (10) | 736 (15) |
| Pre Hypertensionc | 89 (4) | 616 (5) | 240 (7) | 945 (10) |
| Hypertensionc | 247 (27) | 1366 (47) | 326 (16) | 1972 (74) |
Notes:
P-values associated with tests of statistical significance for differences in costs relative to enrollees with BMI under the 85th percentile are .314 for inpatient and <.001 for outpatient, pharmacy and total costs.
P-values associated with tests of statistical significance for differences in costs relative to enrollees with BMI under the 85th percentile are .022 for inpatient and <.001 for outpatient, pharmacy, and total costs.
P-values associated with tests of statistical significance for differences in costs relative to enrollees with normal BP are <.001 for inpatient, outpatient, pharmacy, and total costs.